INFRONEER Holdings Inc. (5076.T)
JPY 1157.5
(0.83%)
JPY 1157.5
(0.83%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 793.26 Billion | 709.64 Billion | 682.91 Billion | 678.05 Billion | 487.85 Billion | 492.08 Billion |
| Cost of Revenue | 681.37 Billion | 611.51 Billion | 591.3 Billion | 588.09 Billion | 420.29 Billion | 426.93 Billion |
| Gross Profit | 111.88 Billion | 98.12 Billion | 91.61 Billion | 89.96 Billion | 67.56 Billion | 65.15 Billion |
| Operating Expenses | 62.09 Billion | 57.62 Billion | 54.12 Billion | 43.61 Billion | 33.51 Billion | 29.2 Billion |
| Selling, General and Administrative Expenses | 56.1 Billion | 45.97 Billion | 41.7 Billion | 38.09 Billion | 27.98 Billion | 25.21 Billion |
| Research and Development Expenses | 5.1 Billion | 4.91 Billion | 5.66 Billion | 5.52 Billion | 5.53 Billion | 3.99 Billion |
| Other Expenses | 884 Million | -43 Million | -553 Million | - | - | - |
| Cost and Expenses | 743.47 Billion | 669.14 Billion | 645.42 Billion | 631.71 Billion | 453.81 Billion | 456.14 Billion |
| Operating Income | 49.78 Billion | 40.49 Billion | 37.48 Billion | 46.34 Billion | 34.04 Billion | 35.94 Billion |
| Interest Expense | 2.83 Billion | 2.26 Billion | 2.57 Billion | 3.21 Billion | 3.59 Billion | 2.19 Billion |
| Income Tax Expense | 16.44 Billion | 14.98 Billion | 14.74 Billion | 16.46 Billion | 10.14 Billion | 10.54 Billion |
| Earnings before Tax | 49.43 Billion | 51.8 Billion | 44.52 Billion | 48.55 Billion | 26.43 Billion | 36.21 Billion |
| Net Income | 32.57 Billion | 33.48 Billion | 26.68 Billion | 23.27 Billion | 14.34 Billion | 23.95 Billion |
| Earnings Per Share Basic | 130.50 | 138.39 | 94.73 | 125.27 | 77.24 | 126.14 |
| Earnings Per Share Diluted | 130.16 | 138.39 | 94.73 | 125.27 | 77.24 | 126.14 |
| Weighted Average Shares Outstanding | 249.57 Million | 259.19 Million | 281.72 Million | 185.8 Million | 185.69 Million | 189.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 250.23 Million | 259.19 Million | 281.72 Million | 185.8 Million | 185.69 Million | 189.89 Million |
| Gross Margin | 0.14 | 0.14 | 0.13 | 0.13 | 0.14 | 0.13 |
| EBIT Margin | 0.11 | 0.11 | 0.11 | 0.11 | 0.10 | 0.10 |
| Profit Margin | 0.04 | 0.05 | 0.04 | 0.03 | 0.03 | 0.05 |
| EBITDA | 83.51 Billion | 80.32 Billion | 69.12 Billion | 77.53 Billion | 48.78 Billion | 49.43 Billion |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.05 | 0.07 | 0.07 | 0.07 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 178.34 Billion | 231.86 Billion | 793.26 Billion | 208.27 Billion | 192.73 Billion | 160.39 Billion |
| Cost of Revenue | 158.57 Billion | 201.81 Billion | 681.37 Billion | 177.74 Billion | 161.81 Billion | 140.01 Billion |
| Gross Profit | 19.77 Billion | 30.05 Billion | 111.88 Billion | 30.53 Billion | 30.91 Billion | 20.37 Billion |
| Operating Expenses | 15.97 Billion | 14.96 Billion | 62.09 Billion | 16.15 Billion | 16.17 Billion | 15.2 Billion |
| Selling, General and Administrative Expenses | 15.97 Billion | 14.56 Billion | - | 13.3 Billion | 13.43 Billion | 12.53 Billion |
| Research and Development Expenses | - | 5.1 Billion | - | 1.2 Billion | 1.09 Billion | 1.02 Billion |
| Other Expenses | 1 Million | - | - | 309 Million | -120 Million | -8 Million |
| Cost and Expenses | 174.55 Billion | 216.77 Billion | 743.47 Billion | 193.89 Billion | 177.98 Billion | 155.21 Billion |
| Operating Income | 3.79 Billion | 16.76 Billion | 49.78 Billion | 14.38 Billion | 14.74 Billion | 5.17 Billion |
| Interest Expense | 1.2 Billion | 2.98 Billion | 4.66 Billion | 596 Million | 558 Million | 525 Million |
| Income Tax Expense | 883 Million | 3.3 Billion | 16.44 Billion | 5.59 Billion | 5.05 Billion | 2.48 Billion |
| Earnings before Tax | 3.62 Billion | 11.8 Billion | 49.43 Billion | 16.34 Billion | 14.71 Billion | 6.57 Billion |
| Net Income | 2.79 Billion | 8.42 Billion | 32.57 Billion | 10.6 Billion | 9.52 Billion | 4.02 Billion |
| Earnings Per Share Basic | 11.32 | 34.31 | - | 42.56 | 37.86 | 15.94 |
| Earnings Per Share Diluted | 10.60 | 33.95 | - | 42.56 | 37.86 | 15.94 |
| Weighted Average Shares Outstanding | 263.39 Million | 248.06 Million | 249.57 Million | 249.24 Million | 251.45 Million | 252.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 263.39 Million | 248.06 Million | 250.23 Million | 249.24 Million | 251.45 Million | 252.32 Million |
| Gross Margin | 0.11 | 0.13 | 0.14 | 0.15 | 0.16 | 0.13 |
| EBIT Margin | 0.07 | 0.06 | - | 0.07 | 0.08 | 0.04 |
| Profit Margin | 0.02 | 0.04 | 0.04 | 0.05 | 0.05 | 0.03 |
| EBITDA | 11.7 Billion | 14.79 Billion | - | 15.51 Billion | 15.31 Billion | 6.65 Billion |
| Earnings Before Tax Margin | 0.02 | 0.07 | 0.06 | 0.07 | 0.08 | 0.03 |
CONCORDBIO
KWI
017900
OCGPF
LTF
GLAND